GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zentek ZEN.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.54

+1.89%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Zentek

Its shares trade on TSX Venture under the ticker ZEN.V. It has been listed since 22 December 2010. In the fiscal year to 31 March 2026, it reported revenue of C$166,048 and a net loss of C$9.8m. At that date it held total assets of C$15.1m and shareholders' equity of C$9.8m.

Zentek Ltd. is an emerging high-tech nano-graphite and graphene materials company. The company is headquartered in Thunder Bay, Ontario. The company went IPO on 2010-12-22. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The firm is focused on the research, development, and commercialization of graphene-based products. The firm's technology helps filter and deactivate pathogens to reduce the risk of transmission. The firm is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The firm is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
22 Dec 2010
Employees
27
Website
zentek.com ↗

Leadership

Pay as last reported

  • Mr. John SnisarenkoIndependent Chairman of the BoardC$94,000
  • Ms. Wendy FordInterim Chief Executive Officer, Chief Financial OfficerC$399,000
  • Mr. Ryan ShacklockSenior Vice President - Strategy and Business DevelopmentC$322,000
  • Dr. Colin Van Der KuurChief Science OfficerC$322,000
  • Mr. Nick HansfordVice President - Strategy and Product DevelopmentC$232,826
  • Mr. Peter WoodVice President - Development (AGC)C$140,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Zentek Ltd. develops graphene-based products for pathogen deactivation and GHG reduction.
  • Zentek's ZenGUARD coating adsorbs bacteria and virus-laden aerosols.
  • Zentek focuses on graphene and nano-materials with unique Albany graphite.

Weaknesses

  • Zentek employs only 27 full-time employees.
  • Zentek's IPO was in 2010 with limited market presence.
  • Zentek's business is based on emerging nano-materials technology.

Opportunities

  • Zentek can expand graphene applications in Health Care and Environmental sectors.
  • Zentek's ZenGUARD addresses public safety needs during pandemics.
  • Zentek's graphene fuel additive reduces GHG emissions from diesel fuels.

Threats

  • Zentek faces competition in the graphene materials industry.
  • Zentek's technology requires significant R&D investment.
  • Zentek's market growth depends on nano-materials adoption rates.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.